Stock GT BIOPHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar GT Biopharma Inc OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for GT Biopharma Inc
27/06 GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 MT
27/06 GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study DJ

Chart calendar GT Biopharma Inc

cb6c4d4512ff3d7b82833a26.VxxsZUdYLgOEEOlnvSomkQq3MYYzmyorTjbHs-nVwik.FlsBCgwIaUHveqUe_nVL50bYX_RFyhgZL1uUwJCvmBoxWF8WABVlbsd3rA~c32635151f99a53e61b94fef202abd94

Upcoming events on GT Biopharma Inc

07/08/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)
18/05/2026 Q1 2026 Earnings Release (Projected)

Past events on GT Biopharma Inc

25/06/2024 11:30 pm Annual General Meeting
16/05/2024 02:30 am Q1 2024 Earnings Release
19/12/2023 12:30 am Extraordinary Shareholders Meeting
05/11/2023 07:30 am Society for Immunotherapy of Cancer Meeting - Abstract No:1180
05/11/2023 12:25 am Society for Immunotherapy of Cancer Meeting - Abstract No:1180
01/11/2023 06:30 pm Q3 2023 Earnings Release
18/08/2023 01:00 am H.C. Wainwright Immune Cell Engager Conference
07/08/2023 06:30 pm Q2 2023 Earnings Release
28/06/2023 11:30 pm Annual General Meeting
25/05/2023 ASTCT EBMT Joint Basic and Translational Scientific Meeting
16/05/2023 06:30 pm PEGS Boston Conference
16/05/2023 02:30 am Q1 2023 Earnings Release
31/03/2023 02:30 am Q4 2022 Earnings Release
28/02/2023 07:30 pm H.C. Wainwright Cell Therapy Virtual Conference
13/12/2022 04:30 am American Society of Hematology Meeting - Abstract Number: 4623
11/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204
11/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202
01/11/2022 02:45 am Q3 2022 Earnings Release
27/10/2022 05:00 am LD Micro Main Event Conference
10/10/2022 11:30 pm Extraordinary Shareholders Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		0,00


-6,76
-6,10
-10.89%		-57,5
-46,2
-24.59%		-21,3
-21,2
-0.2%		-13,6
-13,9
2.65%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-28,3
-16,9
-67.12%		-58,0
-46,6
-24.61%		-20,9
-21,5
2.87%		-7,60
-8,17
7.04%
Net income
Million USD		Released
Forecast
Spread 		-38,6


-28,3
-16,9
-67.12%		-58,0
-46,3
-25.2%		-20,9
-21,5
3%		-7,60
-8,17
7.04%
EPS
USD		Released
Forecast
Spread 		-342


-194
-6,75
-2766.67%		-61,8
-49,4
-25.1%		-19,8
-20,1
1.49%		-5,64
-6,00
6%
Announcement Date27/03/2016/04/2128/03/2230/03/2326/03/24

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-5,44
-7,45
26.95%		-3,01
-5,96
49.4%		-7,02
-3,83
-83.15%		-5,78
-5,73
-0.93%		-3,67
-5,70
35.7%		-3,62
-4,15
12.75%		-3,12
-3,95
20.96%		-3,17
-3,54
10.43%		-3,09
-3,88
20.38%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%		-2,27
-3,88
41.63%
Net income
Million USD		Released
Forecast
Spread 		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%		-2,27
-3,88
41.63%
EPS
USD		Released
Forecast
Spread 		-5,10
-6,90
26.09%		-3,00
-5,40
44.44%		-6,60
-3,30
-100%		-5,40
-5,70
5.26%		-0,30
-4,80
93.75%		-1,50
-3,00
50%		-1,80
-3,00
40%		-5,52
-2,70
-104.44%		-1,64
-2,70
39.26%
Announcement Date16/05/2215/08/2231/10/2230/03/2315/05/2307/08/2301/11/2326/03/2415/05/24

Upcoming sector events for GT Biopharma Inc

04/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
11/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
16/07/2024 CAMURUS AB: Q2 2024 Earnings Release
17/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 04:15 pm JOHNSON & JOHNSON: Q2 2024 Earnings Release
18/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 10:30 am NOVARTIS AG: Q2 2024 Earnings Release
22/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
22/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
23/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for GT Biopharma Inc

21/06/2024 08:58 pm DEVA HOLDING: Q1 2024 Earnings Release
14/06/2024 02:51 am EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 11:00 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 04:03 pm SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 02:47 pm LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 05:38 pm SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 04:30 pm ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 11:54 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 05:30 pm FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 02:56 pm JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Stock
  5. Calendar GT Biopharma Inc